Literature DB >> 27569559

The Yersinia Virulence Factor YopM Hijacks Host Kinases to Inhibit Type III Effector-Triggered Activation of the Pyrin Inflammasome.

Lawton K Chung1, Yong Hwan Park2, Yueting Zheng3, Igor E Brodsky4, Patrick Hearing3, Daniel L Kastner2, Jae Jin Chae2, James B Bliska5.   

Abstract

Pathogenic Yersinia, including Y. pestis, the agent of plague in humans, and Y. pseudotuberculosis, the related enteric pathogen, deliver virulence effectors into host cells via a prototypical type III secretion system to promote pathogenesis. These effectors, termed Yersinia outer proteins (Yops), modulate multiple host signaling responses. Studies in Y. pestis and Y. pseudotuberculosis have shown that YopM suppresses infection-induced inflammasome activation; however, the underlying molecular mechanism is largely unknown. Here we show that YopM specifically restricts the pyrin inflammasome, which is triggered by the RhoA-inactivating enzymatic activities of YopE and YopT, in Y. pseudotuberculosis-infected macrophages. The attenuation of a yopM mutant is fully reversed in pyrin knockout mice, demonstrating that YopM inhibits pyrin to promote virulence. Mechanistically, YopM recruits and activates the host kinases PRK1 and PRK2 to negatively regulate pyrin by phosphorylation. These results show how a virulence factor can hijack host kinases to inhibit effector-triggered pyrin inflammasome activation.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27569559      PMCID: PMC5025386          DOI: 10.1016/j.chom.2016.07.018

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  50 in total

1.  Biochemical characterization of the Yersinia YopT protease: cleavage site and recognition elements in Rho GTPases.

Authors:  Feng Shao; Panayiotis O Vacratsis; Zhaoqin Bao; Katherine E Bowers; Carol A Fierke; Jack E Dixon
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-21       Impact factor: 11.205

2.  A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes.

Authors:  N A Thornberry; H G Bull; J R Calaycay; K T Chapman; A D Howard; M J Kostura; D K Miller; S M Molineaux; J R Weidner; J Aunins
Journal:  Nature       Date:  1992-04-30       Impact factor: 49.962

3.  Effect of Yersinia pestis YopM on experimental plague.

Authors:  J Nemeth; S C Straley
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

4.  The C-terminal tail of Yersinia pseudotuberculosis YopM is critical for interacting with RSK1 and for virulence.

Authors:  Melissa W McCoy; Meghan L Marré; Cammie F Lesser; Joan Mecsas
Journal:  Infect Immun       Date:  2010-04-05       Impact factor: 3.441

5.  Delineation of regions of the Yersinia YopM protein required for interaction with the RSK1 and PRK2 host kinases and their requirement for interleukin-10 production and virulence.

Authors:  Joseph B McPhee; Patricio Mena; James B Bliska
Journal:  Infect Immun       Date:  2010-06-01       Impact factor: 3.441

6.  The ability to replicate in macrophages is conserved between Yersinia pestis and Yersinia pseudotuberculosis.

Authors:  Céline Pujol; James B Bliska
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

7.  Molecular cloning of the interleukin-1 beta converting enzyme.

Authors:  D P Cerretti; C J Kozlosky; B Mosley; N Nelson; K Van Ness; T A Greenstreet; C J March; S R Kronheim; T Druck; L A Cannizzaro
Journal:  Science       Date:  1992-04-03       Impact factor: 47.728

8.  BI-D1870 is a specific inhibitor of the p90 RSK (ribosomal S6 kinase) isoforms in vitro and in vivo.

Authors:  Gopal P Sapkota; Lorna Cummings; Felicity S Newell; Christopher Armstrong; Jennifer Bain; Morten Frodin; Matthias Grauert; Matthias Hoffmann; Gisela Schnapp; Martin Steegmaier; Philip Cohen; Dario R Alessi
Journal:  Biochem J       Date:  2007-01-01       Impact factor: 3.857

9.  Caspase-11 activation in response to bacterial secretion systems that access the host cytosol.

Authors:  Cierra N Casson; Alan M Copenhaver; Erin E Zwack; Hieu T Nguyen; Till Strowig; Bahar Javdan; William P Bradley; Thomas C Fung; Richard A Flavell; Igor E Brodsky; Sunny Shin
Journal:  PLoS Pathog       Date:  2013-06-06       Impact factor: 6.823

10.  The inflammasome pyrin contributes to pertussis toxin-induced IL-1β synthesis, neutrophil intravascular crawling and autoimmune encephalomyelitis.

Authors:  Aline Dumas; Nathalie Amiable; Juan Pablo de Rivero Vaccari; Jae Jin Chae; Robert W Keane; Steve Lacroix; Luc Vallières
Journal:  PLoS Pathog       Date:  2014-05-29       Impact factor: 6.823

View more
  65 in total

1.  The NLRP6 Inflammasome Recognizes Lipoteichoic Acid and Regulates Gram-Positive Pathogen Infection.

Authors:  Hideki Hara; Sergey S Seregin; Dahai Yang; Koichi Fukase; Mathias Chamaillard; Emad S Alnemri; Naohiro Inohara; Grace Y Chen; Gabriel Núñez
Journal:  Cell       Date:  2018-11-01       Impact factor: 41.582

Review 2.  CNF1-like deamidase domains: common Lego bricks among cancer-promoting immunomodulatory bacterial virulence factors.

Authors:  Mengfei Ho; Amel Mettouchi; Brenda A Wilson; Emmanuel Lemichez
Journal:  Pathog Dis       Date:  2018-07-01       Impact factor: 3.166

3.  Redundant and Cooperative Roles for Yersinia pestis Yop Effectors in the Inhibition of Human Neutrophil Exocytic Responses Revealed by Gain-of-Function Approach.

Authors:  Amanda R Pulsifer; Aruna Vashishta; Shane A Reeves; Jennifer K Wolfe; Samantha G Palace; Megan K Proulx; Jon Goguen; Sobha R Bodduluri; Bodduluri Haribabu; Silvia M Uriarte; Matthew B Lawrenz
Journal:  Infect Immun       Date:  2020-02-20       Impact factor: 3.441

4.  Methods for Detection of Pyrin Inflammasome Assembly in Macrophages Infected with Yersinia spp.

Authors:  Natasha P Medici; James B Bliska
Journal:  Methods Mol Biol       Date:  2019

5.  Guanylate Binding Proteins Regulate Inflammasome Activation in Response to Hyperinjected Yersinia Translocon Components.

Authors:  Erin E Zwack; Eric M Feeley; Amanda R Burton; Baofeng Hu; Masahiro Yamamoto; Thirumala-Devi Kanneganti; James B Bliska; Jörn Coers; Igor E Brodsky
Journal:  Infect Immun       Date:  2017-09-20       Impact factor: 3.441

Review 6.  Homeostasis-altering molecular processes as mechanisms of inflammasome activation.

Authors:  Adrian Liston; Seth L Masters
Journal:  Nat Rev Immunol       Date:  2017-02-06       Impact factor: 53.106

Review 7.  Monogenic autoinflammatory disorders: Conceptual overview, phenotype, and clinical approach.

Authors:  Peter A Nigrovic; Pui Y Lee; Hal M Hoffman
Journal:  J Allergy Clin Immunol       Date:  2020-11       Impact factor: 10.793

Review 8.  Activation and pathogenic manipulation of the sensors of the innate immune system.

Authors:  Charlotte Odendall; Jonathan C Kagan
Journal:  Microbes Infect       Date:  2017-01-14       Impact factor: 2.700

Review 9.  The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation.

Authors:  Kalpana Manthiram; Qing Zhou; Ivona Aksentijevich; Daniel L Kastner
Journal:  Nat Immunol       Date:  2017-07-19       Impact factor: 25.606

10.  Characterization of Pyrin Dephosphorylation and Inflammasome Activation in Macrophages as Triggered by the Yersinia Effectors YopE and YopT.

Authors:  Natasha P Medici; Maheen Rashid; James B Bliska
Journal:  Infect Immun       Date:  2019-02-21       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.